A dynamic leader in pharmaceutical contract manufacturing, born from the merger of Mipharm and Doppel, two renowned names in the industry. We specialize in a full spectrum of development, from R&D to regulatory support, with a focus on compliance across all production stages. Our portfolio includes pharmaceuticals, supplements and cosmetic products. As part of our expanding group, we also include Alfa Omega, a player in dietary supplements and homeopathic medicines. Committed to high standards of quality and safety, DMX PHARMA sets the pace for innovation in global healthcare.
| Website | http://www.dmxpharma.com |
| Employees | 38 (20 on RocketReach) |
| Founded | 2024 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Cdmo, Pharmaceutical Contract Manufacturing, Contract Manufacturing Organization, Full Service Cdmo, Pharmaceutical Development, Pharmaceutical Manufacturing, Drug Development Services, R&D Services, Drug Manufacturing, Pharmaceutical Research, Pharmaceutical Formulation, Api Manufacturing, Clinical Trial Manufacturing, Drug Substance Manufacturing, Drug Product Manufacturing, Sterile Manufacturing, Solid Dose Manufacturing |
Looking for a particular DMX PHARMA employee's phone or email?
Andrea Fulvi is the Executive Vice President and Managing Director of DMX PHARMA.
20 people are employed at DMX PHARMA.